Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rebekka Schairer
Observed names:
R. Schairer,
Rebekka Schairer-Marquardt,
Schairer, Rebekka
Institution:
Universitätsklinikum Tübingen
Observed institutions:
University of Bonn,
German Cancer Research Center,
Universitätsklinikum Tübingen,
Universitäts Frauenklinik,
Deutsches Konsortium für Translationale Krebsforschung,
University of Tübingen,
University of Lausanne
show all 7
ORCID:
0000-0001-8686-5053
Observed ORCID:
0000-0001-8686-5053
OpenAlex ID:
A5058003132
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
2023
·
Ann-Christin Pecher
, Luca Hensen
, et al.
·
JAMA
·
275
SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2013
·
Petra M. Bareiss
, Anna Paczulla
, et al.
·
Cancer Research
·
162
CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17–Mediated Psoriasiform Skin Inflammation In Vivo
2018
·
Mark Mellett
, Barbara Meier
, et al.
·
Journal of Investigative Dermatology
·
101
PDF
Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma
2014
·
Andreas Schröck
, Maike Bode
, et al.
·
Carcinogenesis
·
79
The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia
2023
·
Estelle Erkner
, Thomas Hentrich
, et al.
·
Oncogene
·
27
PDF
Relapse after anti-CD19 CAR T-cell therapy in a patient with severe rheumatoid arthritis and multiple sclerosis effectively treated by autologous stem cell transplantation
2025
·
Ann-Christin Pecher
, Luca Hensen
, et al.
·
Annals of the Rheumatic Diseases
·
24
CD19-targeting CAR T cell therapy in five patients with systemic sclerosis unsuitable for autologous stem cell transplantation
2025
·
Ann-Christin Pecher
, Luca Hensen
, et al.
·
EULAR Rheumatology Open
·
20
PDF
Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domain
2020
·
Rebekka Schairer
, Gareth Hall
, et al.
·
Proceedings of the National Academy of Sciences
·
19
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein
2020
·
Jing Cheng
, Linda R. Klei
, et al.
·
Journal of Clinical Investigation
·
19
PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity
2024
·
Emmanuelle Moraes Ribeiro
, Kathy-Ann Secker
, et al.
·
Journal for ImmunoTherapy of Cancer
·
10
PDF
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
2023
·
Rahel Fitzel
, Kathy-Ann Secker-Grob
, et al.
·
Neoplasia
·
9
PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation
2024
·
Daniela Chmiest
, Silvia Podavini
, et al.
·
Blood Advances
·
8
PDF
CD19-chimeric antigen receptor-invariant natural killer T cells transactivate NK cells and reduce alloreactivity
2024
·
Anton Wesle
, Emmanuelle Moraes Ribeiro
, et al.
·
Cytotherapy
·
6
PDF
Anti CD19 targeting CAR T cell therapy in ANCA-associated vasculitis
2026
·
Luisa Schneider
, Ann-Christin Pecher
, et al.
·
Rheumatology
·
5
993 CARD14 gain-of-function mutation alone is sufficient to drive IL-23/IL-17-mediated psoriasiform skin inflammation in vivo
2018
·
M. Mellett
, B. Meier
, et al.
·
Journal of Investigative Dermatology
·
2
Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model
2026
·
Pia Radszuweit
, Rahel Fitzel
, et al.
·
Neoplasia
·
1
Supplementary Figure 2 from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
PDF
Supplementary Methods from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
Supplementary Figure Legends from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
Supplementary Figure 6 from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
Supplementary Figure 7 from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
PDF
Supplementary Figure 4 from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
Supplementary Figure 3 from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
PDF
Supplementary Figure 5 from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
PDF
Supplementary Figure 1 from SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
2023
·
Petra M. Bareiss
, Anna Paczulla
, et al.
PDF
Show more works
View as search
Works count:
29
Citation count:
767
H-index:
10
I10-index:
10
Year
Topic
Type